Cipla Limited • Pharmaceutical preparations NES,Mumbai

Cipla Limited, headquartered in Mumbai, India, is a globally recognized manufacturer, exporter, and service provider in the pharmaceutical and healthcare sectors. Serving respiratory, cardiovascular, anti-infective, HIV/AIDS, oncology, CNS, and consumer health industries, Cipla operates 47 manufacturing sites and distributes over 1,500 products across 80+ countries with a strong presence in India, North America, South Africa, and emerging markets.
Cipla's product portfolio includes generic and complex generics (tablets, injectables, inhalers, topicals) across key therapies—respiratory (Salbutamol, Formoterol/Budesonide), cardiovascular, diabetes, oncology, CNS, urology, and anti-infectives. It’s the world’s largest ARV manufacturer, offers biosimilars in collaboration with Kemwell and Alvotech, consumer health and OTC products, APIs, and digital health solutions—with strong pipeline in biosimilars, specialty, and diagnostics backed by robust R&D.